Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.
Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check39 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check53 days agoChange DetectedOn November 19, 2024, new content was added, while on November 14, 2024, a detailed section regarding data download options and study information fields was removed.SummaryDifference14%
- Check60 days agoChange DetectedOn November 14, 2024, new content was added, while several important government health-related websites were removed from the monitored list on September 23, 2024.SummaryDifference1%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and enhancing the data download options, while the previous version 2.12.1 has been removed.SummaryDifference17%
Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.